In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at ...
The R&D organization had an outsize influence on 20th-century technologies. What was the secret to its success?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results